Literature DB >> 10812705

Permanent alopecia following chemotherapy and bone marrow transplantation.

D Tran1, R D Sinclair, A P Schwarer, C W Chow.   

Abstract

Alopecia can be a psychologically daunting prospect for people requiring cancer chemotherapy. Fortunately, most patients experience only temporary hair loss. We report the case of a 23-year-old woman with chronic myeloid leukaemia who developed permanent, near-total alopecia of her scalp, eyebrows, eyelashes, axillary and public hair following busulphan and cyclophosphamide chemotherapy which was used as conditioning prior to allogeneic bone marrow transplantation. The histology from a scalp biopsy revealed hair follicle destruction. Topical minoxidil failed to induce significant re-growth.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10812705     DOI: 10.1046/j.1440-0960.2000.00405.x

Source DB:  PubMed          Journal:  Australas J Dermatol        ISSN: 0004-8380            Impact factor:   2.875


  10 in total

1.  Treatment and prevention of chemotherapy-induced alopecia with PTH-CBD, a collagen-targeted parathyroid hormone analog, in a non-depilated mouse model.

Authors:  Ranjitha Katikaneni; Tulasi Ponnapakkam; Osamu Matsushita; Joshua Sakon; Robert Gensure
Journal:  Anticancer Drugs       Date:  2014-01       Impact factor: 2.248

Review 2.  Protection against chemotherapy-induced alopecia.

Authors:  Jie Wang; Ze Lu; Jessie L-S Au
Journal:  Pharm Res       Date:  2006-11       Impact factor: 4.200

Review 3.  A Clinical and Biological Guide for Understanding Chemotherapy-Induced Alopecia and Its Prevention.

Authors:  Christopher John Dunnill; Wafaa Al-Tameemi; Andrew Collett; Iain Stuart Haslam; Nikolaos Theodoros Georgopoulos
Journal:  Oncologist       Date:  2017-09-26

4.  Permanent diffuse alopecia after haematopoietic stem cell transplantation in childhood.

Authors:  D Bresters; D C M Wanders; M Louwerens; L M Ball; M Fiocco; R van Doorn
Journal:  Bone Marrow Transplant       Date:  2017-03-20       Impact factor: 5.483

Review 5.  Hair disorders in cancer survivors.

Authors:  Azael Freites-Martinez; Jerry Shapiro; Corina van den Hurk; Shari Goldfarb; Joaquin J Jimenez; Anthony M Rossi; Ralf Paus; Mario E Lacouture
Journal:  J Am Acad Dermatol       Date:  2018-04-14       Impact factor: 11.527

6.  Assessment and Treatment Outcomes of Persistent Radiation-Induced Alopecia in Patients With Cancer.

Authors:  Gregory S Phillips; Morgan E Freret; Danielle Novetsky Friedman; Sabrina Trelles; Oluwaseun Kukoyi; Azael Freites-Martinez; Robin H Unger; Joseph J Disa; Leonard H Wexler; Christopher L Tinkle; James G Mechalakos; Stephen W Dusza; Kathryn Beal; Suzanne L Wolden; Mario E Lacouture
Journal:  JAMA Dermatol       Date:  2020-09-01       Impact factor: 10.282

7.  The role of bimatoprost eyelash gel in chemotherapy-induced madarosis: an analysis of efficacy and safety.

Authors:  Carrie L Morris; Ss Stinnett; Ja Woodward
Journal:  Int J Trichology       Date:  2011-07

8.  Clinical and histological study of permanent alopecia after bone marrow transplantation.

Authors:  Flávia Machado Alves Basilio; Fabiane Mulinari Brenner; Betina Werner; Graziela Junges Crescente Rastelli
Journal:  An Bras Dermatol       Date:  2015 Nov-Dec       Impact factor: 1.896

9.  Pattern of Adverse Drug Reactions to Anticancer Drugs: A Quantitative and Qualitative Analysis.

Authors:  Shruti Singh; D C Dhasmana; Manisha Bisht; Prashant Kumar Singh
Journal:  Indian J Med Paediatr Oncol       Date:  2017 Apr-Jun

10.  Permanent chemotherapy-induced alopecia after hematopoietic stem cell transplantation treated with low-dose oral minoxidil.

Authors:  Anna Lyakhovitsky; Oz Segal; Alexander Maly; Abraham Zlotogorski; Aviv Barzilai
Journal:  JAAD Case Rep       Date:  2022-02-17
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.